Cargando…

UHRF1 is a novel diagnostic marker of lung cancer

BACKGROUND: Lung cancer is the leading cause of cancer deaths worldwide. As the sensitivity and specificity of current diagnostic markers are not perfect, we examined whether ubiquitin-like with PHD and ring finger domains 1 (UHRF1), which is overexpressed in various cancers but not yet examined in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unoki, M, Daigo, Y, Koinuma, J, Tsuchiya, E, Hamamoto, R, Nakamura, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906730/ https://www.ncbi.nlm.nih.gov/pubmed/20517312 http://dx.doi.org/10.1038/sj.bjc.6605717

Ejemplares similares

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
por: Unoki, M, et al.
Publicado: (2009)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
por: Shimizu, K, et al.
Publicado: (2014)

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer
por: Oshita, F, et al.
Publicado: (2006)

Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity
por: Ninomiya, H, et al.
Publicado: (2006)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
por: Yokota, N, et al.
Publicado: (2009)

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
por: Qiao, G-B, et al.
Publicado: (2005)

Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer
por: Matsumoto, Akiko, et al.
Publicado: (2017)

Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
por: Ishikawa, K, et al.
Publicado: (2008)

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
por: Sakakibara, T, et al.
Publicado: (2005)

Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival
por: Kuang, B-H, et al.
Publicado: (2013)

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer
por: Kim, J C, et al.
Publicado: (2013)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
por: Dzieȩgiel, P, et al.
Publicado: (2010)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients
por: Mavridis, K, et al.
Publicado: (2015)

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
por: Takeshita, N, et al.
Publicado: (2013)

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
por: Schache, A G, et al.
Publicado: (2013)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Lack of correlation of stem cell markers in breast cancer stem cells
por: Liu, Y, et al.
Publicado: (2014)

Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases
por: Kita, Y, et al.
Publicado: (2009)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

Urinary N(1), N(12)-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer
por: Takahashi, Yusuke, et al.
Publicado: (2015)

Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
por: Meng, X N, et al.
Publicado: (2009)

Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma
por: Kobayashi, M, et al.
Publicado: (2012)

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
por: Morimura, R, et al.
Publicado: (2011)

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011)

A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies
por: Lee, N, et al.
Publicado: (2007)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer
por: Matsushita, R, et al.
Publicado: (2015)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
por: Hiraoka, N, et al.
Publicado: (2010)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
por: Lee, S, et al.
Publicado: (2010)

Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
por: Li, J, et al.
Publicado: (2009)

Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer
por: Zhu, C-Q, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_p3atvnohvpo1plp082j4btgfk4